Expert Perspectives on SGLT2 Inhibitors: Reviewing Their Role in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease

Educational Activity

This OnDemand satellite symposium consists of a presentation from an expert faculty and 3D animation technology to discuss the role of SGLT2 in the management of patients with diabetes, heart failure, and/or chronic kidney disease, including an overview of key clinical trials.

 

This educational activity is intended for Endocrinologists, Cardiologists, Nephrologists, Primary Care Physicians, Hospitalists, Physician Assistants, Nurse Practitioners, Pharmacists, Certified Diabetes Educators, Managed Care HCPs, and other HCPs who care for patients with diabetes.

 

This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM). This activity is supported by an independent medical education grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

 

Original recording Date: September 12, 2021

 

 

 

 

 

 

 

 

 

Upon completion of the activity, participants will demonstrate improved competence and ability to:

 

  • Identify patients with T2DM, heart failure or chronic kidney disease who would benefit from an SGLT2 inhibitor
  • Apply guidelines and scientific evidence to the management of cardiovascular and/or renal risk in patients with T2DM
  • Explain the mechanisms of action of SGLT-2 inhibitors in T2DM, heart failure, and chronic kidney disease
  • Analyze clinical trial data on the use of SGLT2 inhibitors for managing cardiovascular and/or renal risk in patients with T2DM

Accreditation Statement

 

In support of improving patient care, The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

The Heart Failure Society of America designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Learners should claim only the credit commensurate with the extent of their participation in the activity.
 

LO_Icon

Credits Available

CME, CNE, & CPE

Powered by Oasis.